Day: April 14, 2026

Over the Past 35 Years, Jean-François Ott and Group OTT Have Developed Over 250 Hospitality, Residential, and Commercial Buildings Valued at Over $4 Billion Throughout Europe SKYX’s Technologies are Expected to Reduce Up to 90% of Time and Cost During Group OTT’s Hotel and Building Renovations and New Builds Across Europe The Agreement Involves the Integration of SKYX’s Technologies Across Existing and Future Assets of Group OTT SKYX is Currently in Discussions with Additional Hotel Groups and Owners Regarding Utilization of Its Smart Advanced Time and Cost Saving Game-Changing Technologies for Hotels and Buildings MIAMI, April 14, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced and smart home platform technology company...

Median overall survival increased by >40% in elraglusib arm compared to the control arm, with a 1-year survival rate of 44% in the elraglusib arm versus 22% in the control arm  18-month survival rate >20% in elraglusib arm compared to 4% in control arm Consistent survival benefit observed across the poorest prognosis patient subgroups, including those with liver metastases and high disease burden 7-40X increases in tumor-infiltrating cytotoxic immune cells and biomarker signals in the elraglusib arm reflect immunomodulatory mechanisms of actionCHICAGO and FORT WORTH, Texas, April 14, 2026 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition...

Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 14, 2026 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today the successful closing of its previously announced offering (the “Offering”) of $450 million aggregate principal amount of 4.345% senior unsecured notes due April 14, 2031 (the “Notes”). The Notes have been assigned a final rating of BBB, with a stable trend, by Morningstar DBRS. The Company used approximately $427.7 million of the net proceeds of the Offering to (i) repay in full the indebtedness owing under its term credit facility, and (ii) repay a portion of the indebtedness owing under its revolving credit facility, with the balance of the net proceeds expected to be used for working capital and other general corporate...

Study will evaluate tumor-specific uptake, safety, tolerability, and preliminary efficacy signals of CLR 125 in refractory TNBC, to determine recommended Phase 2 dose FLORHAM PARK, N.J., April 14, 2026 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the first patient has been enrolled in the Phase 1b trial of CLR 121125 (CLR 125) for the potential treatment of triple negative breast cancer (TNBC). CLR 125 is Cellectar’s proprietary Auger-emitting radioconjugate incorporating iodine-125 to achieve intracellular delivery and direct DNA-level damage in tumor cells. The molecular structure of CLR 125 is identical to that of iopofosine I 131 (CLR 131) and the demonstrated clinical...

Driving Mobilicom’s expansion in the growing Asia-Pacific market for unmanned systems Palo Alto, California, April 14, 2026 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced it has secured an initial order from a new customer in the Asia-Pacific (APAC) region. The design win includes an order for Mobilicom’s end-to-end systems that will be integrated into an Intelligence, Surveillance and Reconnaissance (ISR) drone platform, expanding Mobilicom’s global footprint into a new and strategic market. The customer selected Mobilicom’s 10” Ground Control System (GCS), SkyHopper PRO and SkyHopper Multiband datalinks, providing highly robust, secure, and resilient communications purpose-built for demanding ISR...

NFPA Certified FireFlex Elite L-100 Boot Delivers Unparalleled Comfort, Protection and Durability for Today’s Extreme Firefighting Environment New Certified Products and Expanded PPE Options to be Showcased at FDIC 2026 April 20-25 Production Set to Commence for Fulfillment of Pre-Orders Received HUNTSVILLE, Ala., April 14, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that the new Lakeland FireFlex Elite-L100 Structural Firefighting Boot has officially achieved NFPA 1970:2025 certification, further strengthening Lakeland’s NFPA certified head-to-toe firefighter Personal Protective Equipment (PPE) portfolio. This certification...